Cepheid Gets CE IVD Mark for C. Difficile Test | GenomeWeb
NEW YORK (GenomeWeb news) – Cepheid has launched its molecular diagnostic test for Clostridium difficile as a European CE IVD Mark product under the European Directive on In Vitro Diagnostic Medical Devices.
 
The PCR-based test runs on the company’s GeneXpert System, and it detects and identifies common strains of the C. difficile infection, including the virulent Type 027 strain that had been reported in 16 European countries through June.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Wall Street Journal reports that National Institutes of Health Director Francis Collins' response to contamination concerns at the agency might have delayed care.

The final revision of the Common Rule doesn't include the proposed change requiring consent for leftover biospecimens.

The first Reproducibility Project: Cancer Biology papers show mixed results.

In Nature this week: mobile phone-based targeted DNA sequencing, and more.